Your browser doesn't support javascript.
loading
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of juvenile idiopathic arthritis in Canada: a scoping review.
Gheshlaghi, Niloofar; Thomas, Megan; Trehan, Natasha; Harrison, Mark; De Vera, Mary A.
Affiliation
  • Gheshlaghi N; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, V6T 1Z3, Vancouver, BC, Canada.
  • Thomas M; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, V6T 1Z3, Vancouver, BC, Canada.
  • Trehan N; Collaboration for Outcomes Research and Evaluation, Vancouver, BC, Canada.
  • Harrison M; Arthritis Research Canada, Vancouver, BC, Canada.
  • De Vera MA; Faculty of Science, University of Ottawa, Ottawa, ON, Canada.
Pediatr Rheumatol Online J ; 21(1): 134, 2023 Nov 06.
Article in En | MEDLINE | ID: mdl-37932754
BACKGROUND: Juvenile Idiopathic Arthritis (JIA) is the most common form of childhood inflammatory arthritis. The disease burden of JIA is substantial as patients require specialized medical practitioners for diagnosis and chronic treatments that are both costly and time intensive. Discrepancies in access to care due to health inequities such as socioeconomic status or geographic location may lead to vastly different health outcomes. As research informs advances in care, is important to consider inclusion and diversity in JIA research. METHODS: We reviewed and synthesized randomized controlled trials for juvenile idiopathic arthritis, the most common type of arthritis among children and adolescents, in Canada with the aim of characterizing participants and identifying how determinants of health inequities are reported. To do so, we searched Medline (1990 to July 2022), Embase (1990 to July 2022), and CENTRAL (inception to July 2022) for articles meeting all of the following criteria: Canadian randomized controlled trials evaluating pharmacological or non-pharmacological interventions on juvenile idiopathic arthritis populations. Data extraction was guided by the Campbell and Cochrane Equity Methods Group's PROGRESS-Plus framework on determinants that lead to health inequities (e.g., Place of residence; Race; Occupation; Gender/Sex; Religion; Education; Socioeconomic status; and Social capital). RESULTS: Of 4,074 unique records, 5 were deemed eligible for inclusion. From these determinants of health inequities, Gender/Sex and Age were the only that were reported in all studies with most participants being female and 12.6 years old on average. In addition, Race, Socioeconomic status, Education and Features of relationships were each reported once in three different studies. Lastly, Place of residence, Occupation, Religion, Social Capital and Time-dependent relationships were not reported at all. CONCLUSIONS: This scoping review suggests limited reporting on determinants of health inequities in randomized controlled trials for JIA in Canada and a need for a reporting framework that reflects typical characteristics of juvenile patient populations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile Type of study: Systematic_reviews Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Pediatr Rheumatol Online J Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile Type of study: Systematic_reviews Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Pediatr Rheumatol Online J Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido